Ebymect

Ebymect combines Metformin Hydrochloride and Dapagliflozin for oral use, aiding blood sugar management. This dual-action medication supports glucose control in adults with type 2 diabetes.

Ebymect is primarily used for managing type 2 diabetes by improving blood sugar levels. It works by reducing glucose absorption in the kidneys and enhancing insulin sensitivity. This medication is often prescribed as part of a broader diabetes management plan, including diet and exercise.

Common effects of Ebymect may include urinary tract infections, nausea, and dizziness. Some users report increased urination frequency due to the diuretic properties of Dapagliflozin. Metformin Hydrochloride can sometimes cause gastrointestinal discomfort.

Ebymect should be used with caution in individuals with kidney issues or a history of urinary tract infections. It is important to stay hydrated while taking this medication. Consult a healthcare provider before starting Ebymect, especially if you have other medical conditions.

Ebymect may interact with certain medications, including diuretics, insulin, and other diabetes drugs. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of side effects. Always inform your healthcare provider about all medications you are taking.